Browsing Tıp Fakültesi by Author "Zuhal Keskin Yildirim"

Now showing items 1-4 of 4

Assessment of Humoral Immunity to Hepatitis B, Measles, Rubella, and Mumps in Children After Chemotherapy

Zuhal Keskin Yildirim; Büyükavcı, Mustafa (LIPPINCOTT WILLIAMS & WILKINS, 2018)

Background:Cancer survival rates and longevity of patients after therapy have significantly improved during the last few decades. Therefore, lasting protection against infections should be provided.Procedure:A total of 162 ...
Clinical experience with recombinant tissue plasminogen activator in the management of intracardiac and arterial thrombosis in children

Hasim Olgun; Mustafa Buyukavci; Naci Ceviz; Irfan Oguz Sahin; Zuhal Keskin Yildirim; Abdurrahim Colak; Kadir Serafettin Tekgunduz; Caner, İbrahim (LIPPINCOTT WILLIAMS & WILKINS, 2014)

Thrombotic events may complicate the clinical course of many pediatric diseases. Drugs for therapeutic thrombolysis include streptokinase, urokinase and tissue plasminogen activator (t-PA). There is less experience with ...
Nutritional Status of Children with Cancer: A Single Center Experience

Esra Disci; Zuhal Keskin Yildirim; Büyükavcı, Mustafa; Cahit Karakelleoglu (GALENOS YAYINCILIK, 2018)

DISCUSSION AND CONCLUSION: Nutritional deficiency in children with cancer at the time of diagnosis is not much more than in children hospitalized due to acute infection. However, a temporary weight loss is observed in ...
The Comparison of The Efficacy and Safety of Original and Biosimilar Filgrastim in Prevention of Chemotherapy-Induced Neutropenia in Children with Cancer

Büyükavcı, Mustafa; Zuhal Keskin Yildirim (AVES, 2019)

Conclusion: The biosimilar filgrastim, Leucostim, is as effective and safe as the original drug for prophylaxis of chemotherapy-induced neutropenia in children.